Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

BACKGROUND: Human species C adenovirus serotype 5 (Ad5) is the archetype oncolytic adenovirus and has been used in the vast majority of preclinical and clinical tests. While Ad5 can be robust, species C Ad6 has lower seroprevalence, side effects, and appears to be more potent as a systemic therapy a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncolytic Virother
Hlavní autoři: Nguyen, Tien V, Crosby, Catherine M, Heller, Gregory J, Mendel, Zachary I, Barry, Mary E, Barry, Michael A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5939883/
https://ncbi.nlm.nih.gov/pubmed/29765912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S155946
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky